These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1083506)

  • 1. [Platelet anomaly in an eosinophilic myelophroliferative syndrome].
    Wautier JL; Dupuy E; Michel H; Caen JP
    Nouv Presse Med; 1976 Mar; 5(11):704-6. PubMed ID: 1083506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The laboratory diagnosis of von Willebrand's disease (author's transl)].
    Niessner H
    Wien Klin Wochenschr; 1976 Apr; 88(7):221-31. PubMed ID: 1086551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A platelet defect in a patient with eosinophilic leukaemia: absent ristocetin-induced platelet aggregation associated with a reduced platelet sialic acid content.
    Wautier JL; Souchon H; Dupuis D; Caen JP; Nurden AT
    Scand J Haematol; 1979 Mar; 22(3):267-76. PubMed ID: 451458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new mode of defective ristocetin-induced platelet aggregation.
    Baugh RF; Hougie C
    J Lab Clin Med; 1981 Jun; 97(6):864-80. PubMed ID: 6971912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
    Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
    Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes].
    Vlădăreanu AM; Popov V; Bumbea H; Ciufu C; Vasilache V; Petre A; Onisâi M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):14-9. PubMed ID: 21688554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ristocetin--a new tool in the investigation of platelet aggregation.
    Howard MA; Firkin BG
    Thromb Diath Haemorrh; 1971 Oct; 26(2):362-9. PubMed ID: 5316292
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
    Landolfi R; Marchioli R; Patrono C
    Thromb Haemost; 1997 Jul; 78(1):617-21. PubMed ID: 9198226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
    Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
    Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet defects in chronic myeloproliferative disorders].
    Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
    Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The sticky platelet syndrome: a frequent but unrecognized cause of thrombophilia].
    Ruiz-Argüelles GJ; Ruiz-Delgado GJ; López-Martínez B
    Rev Invest Clin; 2002; 54(5):394-6. PubMed ID: 12587412
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis.
    Favaloro EJ; Patterson D; Denholm A; Mead S; Gilbert A; Collins A; Estell J; George PM; Smith MP
    Br J Haematol; 2007 Nov; 139(4):623-6. PubMed ID: 17916098
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelets in the myeloproliferative syndrome.
    Weinfeld A; Branehög I; Kutti J
    Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.